ArticleOncology research2018

Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of a Single Institution.

Wang Fangzheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.